The Thai Red Cross Society Prevention of Mother-To-Child Transmission of HIV (TRCS PMTCT) Program

NCT02151838 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2021-07-12

No results posted yet for this study

Summary

To assess the safety and the efficacy of Highly Active Anti-Retroviral Treatment (HAART) for the Prevention of Mother-To-Child Transmission of HIV (PMTCT)

Conditions

  • HIV-infected Pregnant Women Who Request HAART From the TRCSPMTCT

Sponsors & Collaborators

  • Thai Red Cross AIDS Research Centre

    lead OTHER

Eligibility

Min Age
15 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2020-12-31
Completion
2021-07-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02151838 on ClinicalTrials.gov